Literature DB >> 1322348

Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus.

K Yoshioka1, S Kakumu, T Wakita, T Ishikawa, Y Itoh, M Takayanagi, Y Higashi, M Shibata, T Morishima.   

Abstract

To investigate the relationship between genotypes of hepatitis C virus and response to interferon-alpha therapy, hepatitis C virus RNA was assayed by polymerase chain reaction with three sets of primers and probes in 70 patients with non-A, non-B chronic hepatitis who received interferon-alpha. Twenty-four patients sustained long-term remissions (complete responders). Polymerase chain reaction for 5'-terminal noncoding region detected hepatitis C virus RNA in 94.3% (66 of 70) of the patients. Polymerase chain reaction for nonstructural region 3, in which primers and a probe were synthesized to be identical to hepatitis C virus-J, detected hepatitis C virus RNA in 40 patients. Polymerase chain reaction for nonstructural region 5-in which sequences of primers and a probe were derived from hepatitis C virus-K2, a genotype different from hepatitis C virus-J--detected hepatitis C virus RNA in 17 patients. Only one patient was positive on both nonstructural region 3 and nonstructural region 5 polymerase chain reaction. Nucleotide sequence of clones obtained from 5' terminal noncoding region polymerase chain reaction products of two patients positive on polymerase chain reaction for nonstructural region 3 and negative on polymerase chain reaction for nonstructural region 5 (group 1) corresponded to that of the hepatitis C virus-J group, and those of clones from two patients negative on polymerase chain reaction for nonstructural region 3 and positive on polymerase chain reaction for nonstructural region 5 (group 2) corresponded to that of hepatitis C virus-K2.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1322348     DOI: 10.1002/hep.1840160203

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  101 in total

1.  High viral eradication with a daily 12-week natural interferon-beta treatment regimen in chronic hepatitis C patients with low viral load. IFN-beta Research Group.

Authors:  Y Shiratori; R Nakata; N Shimizu; H Katada; S Hisamitsu; E Yasuda; M Matsumura; T Narita; K Kawada; M Omata
Journal:  Dig Dis Sci       Date:  2000-12       Impact factor: 3.199

2.  Decrease of HCVRNA after three days of daily interferon treatment is predictive of the virological response at one month.

Authors:  A Magalini; M Puoti; V Putzolu; E Quiros-Roldan; M A Forleo; S Rossi; S Zaltron; A Spinetti; B Zanini; A Zonaro; R Solfrini; G Carosi
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

Review 3.  Hepatitis C in childhood.

Authors:  F Bortolotti
Journal:  Indian J Pediatr       Date:  1995 Sep-Oct       Impact factor: 1.967

4.  The Effect Of Long Term and High Dose Interferon Treatment In Chronic Hepatitis C.

Authors:  Gábor Horváth; Gyula Stotz; Gyula Tolvaj; Henrik Osztrogonácz; Károly Dávid
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

Review 5.  Peginterferon and ribavirin treatment for hepatitis C virus infection.

Authors:  Akihito Tsubota; Kiyotaka Fujise; Yoshihisa Namiki; Norio Tada
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

6.  Interferon-alpha for reinfection with hepatitis C virus in two patients with chronic hepatitis C who had responded to previous therapies.

Authors:  Norio Akuta; Fumitaka Suzuki; Akihito Tsubota; Yoshiyuki Suzuki; Takashi Someya; Masahiro Kobayashi; Satoshi Saitoh; Yasuji Arase; Kenji Ikeda; Yuzo Miyakawa; Hiromitsu Kumada
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

7.  Management of chronic hepatitis C and prevention of hepatocellular carcinoma.

Authors:  Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

8.  Phylogenetic analysis of hepatitis C virus isolates from Tunisian patients.

Authors:  Ahlem Djebbi; Selma Mejri; Valerie Thiers; Henda Triki
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

9.  Interferon treatment of chronic hepatitis C in patients with hemophilia or von Willebrand's disease in Japan.

Authors:  M Yoshikawa; H Fukui; H Kojima; H Yoshiji; T Sakamoto; H Imazu; T Nakanani; Y Matsumura; S Kuriyama; J Yamao
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

10.  Hepatocyte regeneration in chronic hepatitis C and interferon treatment: analysis of immunohistological identification of proliferating cell nuclear antigen (PCNA).

Authors:  M Hamada; T Kihira; K Takase; T Nakano; Y Tameda; Y Kosaka
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.